Cell and Gene Outsourcing
-
Lentiviral Solutions: Fast Lane To The Clinic
10/16/2025
Vector redesign and regulatory hurdles can add years to development timelines. A single-partner approach helps streamline the process, secures timelines, and ensures smooth tech transfer to the clinic.
-
The Future Of CGT: Phase-Appropriate Plasmid DNA Manufacturing
10/16/2025
Effective CGT development hinges on phase-appropriate manufacturing. Matching manufacturing rigor to the clinical phase ensures the right quality at the right time while reducing costs and accelerating timelines.
-
Proven Expertise And Customized End-To-End Solutions For Your Products
10/16/2025
Access customized end-to-end solutions. Expertise spans process development, drug substance manufacturing, and aseptic fill/finish, with broad technology for vaccines and cell and gene therapy.
-
Streamline Biopharmaceutical Manufacturing With Versatile Platforms
10/16/2025
Gain insights into how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.
-
Accelerate Drug Development With Reliable Pharmaceutical Research
10/16/2025
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
Biosimilar Development: Early-Stage Characterization To QC Release
10/15/2025
SGS provides a complete range of bioanalytical solutions, including method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, immunogenicity testing.
-
Mabion Capacity Update October 2025: Analytical Services
10/15/2025
We offer an end-to-end solution, covering every stage of biologic drug development, from early clone selection and small-scale manufacturing to process scale-up, large-scale production, and quality control.
-
KBI Biopharma Capacity Update October 2025: Analytical Services
10/15/2025
Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines from discovery through commercialization.
-
Alcami Capacity Update October 2025: Analytical Services
10/15/2025
Whether you're preparing for IND, scaling commercial operations, or navigating complex regulatory pathways, gain actionable strategies and updates to help you move forward with confidence.
-
IVD And CDx: Comprehensive Services From Research To Regulatory
10/15/2025
Navigating diagnostic development requires deep scientific expertise and adept regulatory support. Comprehensive solutions offer biospecimens, biomarker development, clinical trial support, and global regulatory services.